For example, rutin (a bioflavonoid found in medicinal herbs and plant-derived foods) interacts with -AAs (i.e., lysine, isoleucine, histidine, or glutamic acid) to generate phenolic-MRPs
Additionally, new PDE4 inhibitors have been developed to modify the inflammatory process and have demonstrated satisfactory clinical outcomes, highlighting the implication of novel therapeutic interventions in treating inflammatory-related disorders
[DOI] [PubMed] [Google Scholar] 111.Hao J, et al
Relevant Updates to the Interim Bulk Drug Substances List for 503A Pharmacies 2,4,5,6 For a full list of updates, please download the complete Bulk Drug Substances Nominated for Use in Compounding Under Section 503A of the Federal Food, Drug, and Cosmetic Act document linked above